// App-Quantinova.ai

EP1175 : QUANTIFYING PATIENT PREFERENCES FOR TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA: A DISCRETE-CHOICE EXPERIMENT

Researchers

Presenter

  • Bradley Mason

Principal Investigators

  • Alexander Russell-Smith

  • Pam Hallworth

  • Adam Gater

  • Slaven Sikirica

  • Tom Gardner

  • Jasmeet Anand

  • Olivia Hughes

  • Carla Mamolo

  • Joseph C. Cappelleri

Medical Centers

  • Pfizer Inc., New York, United States

  • Pfizer Groton CT United States

  • Adelphi Values, Cheshire, United Kingdom

  • Adelphi Research,Cheshire,United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

  • Tuberculosis

Biomarkers

  • N/A

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved